Processa Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Processa Pharmaceuticals, Inc. (PCSA) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -0.01% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-03-18
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2025 was -0.01%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -0.05%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -1.41%.
- Processa Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -0.93%, a 130.59% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.01% 10-K · filed 2026-03-18 | |
| 2024-12-31 | -0.05% 10-K · filed 2026-03-18 | |
| 2023-12-31 | -1.41% 10-K · filed 2025-03-20 | |
| 2022-12-31 | -0.93% 10-K · filed 2024-03-29 | 0.93% 10-K · filed 2023-03-30 |
| 2021-12-31 | 3.04% 10-K · filed 2023-03-30 | |
| 2020-12-31 | 0.94% 10-K · filed 2022-03-30 | |
| 2019-12-31 | 7.15% 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |